None listed
Conditions
Interventions
None listed
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: •1. Men undergoing a first-time prostate biopsy to rule out cancer •2. Serum PSA =3ng/mL, =20ng/mL •3. Age=50 years, =80 years •4. Clinical stage =T2c •5. Patients must be able to provide written informed consent.
Exclusion criteria
Exclusion criteria: •1. Patients has any prior needle biopsy of the prostate •2. Patients has a prior history of prostate cancer •3. Patients has a prior history of pelvic radiation therapy or androgen deprivation therapy •4. Patients has a prior history of BPH operation •5. Patient with uncorrectable coagulopathies •6. Unable to tolerate a TRUS guided biopsy. •7. Patients had 5-alpha reductase inhibitor in the past six months. •8. The patient has had a urinary tract infection or acute prostatitis in the last three months. •9. Any contraindication to MRI (severe claustrophobia, pacemaker, MRI-incompatible prosthesis, eGFR =50mls/min)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Proportion of clinically significant prostate cancer (=Gleason score 3+4) [ Time Frame: 2 week after the procedure ] | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Proportion of clinically insignificant prostate cancer (Gleason score 6) [ Time Frame: 2 week after the procedure ] | — |
Countries
Korea, Republic of
Contacts
Public ContactBumjin Lim
Asan Medical Center
Outcome results
None listed